An investigation on behalf of investors of Envision Healthcare Corporation (NYSE: EVHC) in connection with the proposed takeover was announced.
San Diego, CA -- (SBWIRE) -- 06/20/2018 -- An investigation was announced concerning the acquisition of Envision Healthcare. by KKR.
Investors who purchased shares of Envision Healthcare Corporation (NYSE: EVHC) and currently hold any of those NYSE: EVHC shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Envision Healthcare Corporation breached their fiduciary duties owed to NYSE: EVHC investors in connection with the proposed acquisition.
On June 11, 2018, Envision Healthcare Corporation (NYSE: EVHC) announced it has entered into a agreement to be acquired by global investment firm KKR in an all-cash transaction for approximately $9.9 billion, including the assumption or repayment of debt. Under the terms of the agreement, KKR will acquire all of the outstanding shares of Envision's common stock for $46.00 per share in cash.
However, given that at least one analyst has set the high target price for NYSE: EVHC shares at $51.00 per share and given that NYSE: EVHC shares traded in 2017 as high as $82.78 per share, the investigation concerns whether the offer is unfair to NYSE: EVHC stockholders. More specifically, the investigation concerns whether the Envision Healthcare Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On June 19, 2018, NYSE: EVHC shares closed at $44.70 per share.
Those who are current investors in Envision Healthcare Corporation (NYSE: EVHC) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels